When:
Saturday, April 21, 2018
10:00 AM - 12:00 PM CT
Where: Prentice Women's Hospital, Room L South, Third Floor, 250 E. Superior, Chicago, IL 60611 map it
Audience: Faculty/Staff - Student - Public - Post Docs/Docs - Graduate Students
Cost: Free
Contact:
Colleen Shinn
Group: Center for Autism and Neurodevelopment
Category: Lectures & Meetings
Discover the latest innovations in science, research and technology related to causes and improved interventions for autism spectrum disorder.
Please join us for a community science event hosted by Autism Speaks Chief Science Officer, Thomas Frazier, PhD.
Dr. Frazier will explore the latest advances in autism research to support people with autism and their families.
Who should attend: Open to all, including people with autism and their families,
researchers, educators, clinicians, policy makers, and members of the local community.
The event is free, but registration is required. RSVP at http://act.autismspeaks.org/site/Calendar?view=Detail&id=101481
Dr. Frazier is a licensed clinical psychologist who received his Ph.D. from Case Western Reserve University in 2004. He joined Cleveland Clinic in 2006 and from 2013-2017 was the director of the Cleveland Clinic Center for Autism. Over the last decade, Dr. Frazier’s research has focused on two areas: 1) using remote eye gaze tracking to improve early identification of autism, and 2) translational studies of the sub-group of autism associated with PTEN mutations. Over the last 3 years, he has published the first studies identifying remote eye tracking measures as predictive of autism risk and symptom levels and the first comprehensive characterization of patients with autism and PTEN mutations. In April of 2017, Dr. Frazier joined Autism Speaks as Chief Science Officer.